Maira Dastgir N on Microvascular Dysfunction in Geriatrics
Maira Dastgir N, Global Chief of Transitional Care for Global Population Healthcare Management Forum, shared on LinkedIn:
”In geriatric care, we often focus on macro events like heart attacks or strokes.
However, the root of many geriatric syndromes like dementia, depression, and frailty often lies at the microvascular level.
I reviewed an interesting article recently that caught my attention, The Maastricht Study findings on alcohol and Microvascular Dysfunction (MVD).
The researchers found a J-shaped association which meant light-to-moderate consumption was linked to lower MVD compared to abstinence, while high consumption worsened it.
As primary care doctors, we are dedicated to prevention and often view alcohol through a binary lens of “healthy” vs. “unhealthy.”
But for our aging population, the microvasculature is the frontline of defense against cognitive decline and physical frailty. This study suggests that:
1) Dietary interventions are not one-size-fits-all. The way a patient’s body handles alcohol and its impact on small vessels depends heavily on their metabolic profile.
2) The “Micro” is the Key to the “Macro”. By the time a patient presents with geriatric syndromes like depression or dementia, microvascular damage may already be advanced. We must broaden our horizons to include early microvascular screening as a preventive standard.
3) While we cannot and should not recommend increasing alcohol intake as a broad policy, we must understand these biological nuances to provide truly personalized geriatric care.
Shifting our focus from large-vessel events to early microvascular screening and dietary nuances can help diagnose minor dysfunction before it becomes a major clinical disease.
I have linked the article here.”
Article: Alcohol consumption and microvascular dysfunction: a J-shaped association: The Maastricht Study
Authors: Frank C. T. van der Heide, Simone J. P. M. Eussen, Alfons J. H. M. Houben, Ronald M. A. Henry, Abraham A. Kroon, Carla J. H. van der Kallen, Pieter C. Dagnelie, Martien C. J. M. van Dongen, Tos T. J. M. Berendschot, Jan S. A. G. Schouten, Carroll A. B. Webers, Marleen M. J. van Greevenbroek, Anke Wesselius, Casper G. Schalkwijk, Annemarie Koster, Jacobus F. A. Jansen, Walter H. Backes, Joline W. J. Beulens, Coen D. A. Stehouwer

Stay updated on all scientific advances with Hemostasis Today.
-
Jun 15, 2026, 12:31Chandrashekhar Athare: EHA 2026 Concludes with Lasting Impact and New Collaborations
-
Jun 15, 2026, 10:49Aurelio Maggio: How Is The Treatment Landscape Of Thrombotic Thrombocytopenic Purpura Evolving?
-
Jun 15, 2026, 10:49Marek Mráz: A Landmark EHA 2026 for Our Lab
-
Jun 15, 2026, 10:32Magnus Ek: Operational Excellence in Delivering Seamless Access for 17,000 Delegates at EHA 2026 Congress
-
Jun 15, 2026, 10:15Carol Bewick: Why the Global Community Makes EHA 2026 Unforgettable
-
Jun 15, 2026, 10:07Habib Bennaceur: Driving Haemoglobinopathies Progress Across Multiple Clinical Programmes At EHA 2026
-
Jun 14, 2026, 22:49Cihan Ay: From First Oral Presentation to Pro and Con Debate – A 20-Year EHA Journey
-
Jun 14, 2026, 19:54Tareq Abadl: What Happens If You Transfuse the Wrong Blood Group?
-
Jun 14, 2026, 19:46Amber Yates: Stretching Scientific Muscles in Areas of Hematology – Day 2 at EHA 2026